NIH #1P50CA302482-01
MD Anderson Sarcoma SPORE
Active
- Amount
- $1.8M
- Period
- 2025-08-19 → 2030-07-31
- PIs
- 2
- Est. capacity / PI
- ~12 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01CA199221-11
Genomically informed agent selection and testing in osteosarcoma patient-derived xenograft models
- Amount
- $405K
- Period
- 2015-07-10 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01CA199221-10
Genomically informed agent selection and testing in osteosarcoma patient-derived xenograft models
- Amount
- $403K
- Period
- 2015-07-10 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01CA199221-09
Genomically informed agent selection and testing in osteosarcoma patient-derived xenograft models
- Amount
- $395K
- Period
- 2015-07-10 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01CA199221-08
Genomically informed agent selection and testing in osteosarcoma patient-derived xenograft models
- Amount
- $397K
- Period
- 2015-07-10 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #2U01CA199221-07
Genomically informed agent selection and testing in osteosarcoma patient-derived xenograft models
- Amount
- $405K
- Period
- 2015-07-10 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3U01CA199221-06S2
Osteosarcoma: Patient Derived Xenograft Preclinical Testing
- Amount
- $160K
- Period
- 2021-02-01 → 2021-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01CA199221-06
Osteosarcoma: Patient Derived Xenograft Preclinical Testing
- Amount
- $351K
- Period
- 2015-07-10 → 2021-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3U01CA199221-06S1
Osteosarcoma: Patient Derived Xenograft Preclinical Testing
- Amount
- $178K
- Period
- 2015-07-10 → 2021-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01CA199221-05
Osteosarcoma: Patient Derived Xenograft Preclinical Testing
- Amount
- $136K
- Period
- 2015-07-10 → 2020-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #7U01CA199221-04
Osteosarcoma: Patient Derived Xenograft Preclinical Testing
- Amount
- $249K
- Period
- 2015-07-10 → 2020-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #6U01CA199221-02
Osteosarcoma: Patient Derived Xenograft Preclinical Testing
- Amount
- $243K
- Period
- 2015-07-10 → 2020-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
NIH #5U01CA199221-03
Osteosarcoma: Patient Derived Xenograft Preclinical Testing
- Amount
- $260K
- Period
- 2015-07-10 → 2016-12-04
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
NIH #1U01CA199221-01
Osteosarcoma: Patient Derived Xenograft Preclinical Testing
- Amount
- $17K
- Period
- 2015-07-10 → 2015-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at ALBERT EINSTEIN COLLEGE OF MEDICINE
NIH #1P01CA106450-01A1
Core E
- Amount
- $116K
- Period
- 2005-07-21 → 2010-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #2R01CA083132-04A2
Antifolate Resistance in Osteosarcoma
- Amount
- $156K
- Period
- 1999-07-01 → 2008-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at ALBERT EINSTEIN COLLEGE OF MEDICINE
NIH #5R01CA083132-07
Antifolate Resistance in Osteosarcoma
- Amount
- $150K
- Period
- 1999-07-01 → 2008-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at ALBERT EINSTEIN COLLEGE OF MEDICINE
NIH #5R01CA083132-06
Antifolate Resistance in Osteosarcoma
- Amount
- $154K
- Period
- 1999-07-01 → 2008-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at ALBERT EINSTEIN COLLEGE OF MEDICINE
NIH #5R01CA083132-05
Antifolate Resistance in Osteosarcoma
- Amount
- $157K
- Period
- 1999-07-01 → 2008-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at ALBERT EINSTEIN COLLEGE OF MEDICINE
NIH #5R01CA083132-03
ANTIFOLATE RESISTANCE OSTEOSARCOMA
- Amount
- $135K
- Period
- 1999-07-01 → 2002-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R01CA083132-02
ANTIFOLATE RESISTANCE OSTEOSARCOMA
- Amount
- $131K
- Period
- 1999-07-01 → 2002-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #1R01CA083132-01
ANTIFOLATE RESISTANCE OSTEOSARCOMA
- Amount
- $127K
- Period
- 1999-07-01 → 2002-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5P01CA106450-05
Core E
- Amount
- $269K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~4 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5P01CA106450-04
Core E
- Amount
- $262K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~4 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5P01CA106450-03
Core E
- Amount
- $260K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~4 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5P01CA106450-02
Core E
- Amount
- $142K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~2 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH